Subscribe

Futures & Options World
Futures & Options World Copying and distributing are prohibited without permission of the publisher
Email a friend
  • To include more than one recipient, please seperate each email address with a semi-colon ';'


NASDAQ OMX and IntercontinentalExchange pull out of bid for NYSE Euronext

16 May 2011

NASDAQ OMX and IntercontinentalExchange have withdrawn their joint proposal to acquire NYSE Euronext following discussions with the Antitrust Division of the US Department of Justice.

Read more: Nasdaq ICE NYSE. exchange mergers Euronext Liffe

NYSE Euronext shares fell over 10% on the news, which came despite Nasdaq proposals to sell off parts of the NYSE Euronext portfolio. The shares are now trading at $37.76 a share, around the level of the Deutsche Börse bid.

Bob Greifeld, NASDAQ OMX CEO said: “We took the decision to withdraw our offer when it became clear that we would not be successful in securing regulatory approval for our proposal despite offering a variety of substantial remedies, including the sale of the NYSE SRO and related businesses.”

The surprise withdrawal from Nasdaq and ICE leaves Deutsche Börse firm favourites to win control of the exchange.

Jeffrey C. Sprecher, ICE Chairman and CEO, said: “We appreciate the strong support of our investors as we made an opportunistic and disciplined move to pursue an attractive combination that would preserve competition in the European derivatives markets. 

“I also want to acknowledge the consideration shown by NYSE Euronext stockholders for our joint proposal, which was undertaken with seriousness and a concern for the evolving global market structure. We will continue to seek opportunities that benefit our customers and stockholders, and that leverage our unique global market infrastructure in commodities, derivatives and clearing.”


Have your say
  • All comments are subject to editorial review.
    All fields are compulsory.

Poll

What concerns you most about the upcoming regulation changes?

Opportunity for regulatory arbitrage
12%
Impact on revenues
36%
Unnecessary complexity
10%
Workability of central clearing for OTC derivatives
11%
Workability of forcing complex derivatives onto exchanges
30%